Home
About
News
Resources
Events
FAQ & Support
Programs
Laws and Regulations Governing Buprenorphine for OUD
Managing the Legal Risks of Prescribing Controlled Medications
Preparing for and Responding to DEA Visits
Prescribing Buprenorphine for OUD During a Public Health Emergency
Home
About
News
Resources
Events
FAQ & Support
Programs
Laws and Regulations Governing Buprenorphine for OUD
Managing the Legal Risks of Prescribing Controlled Medications
Preparing for and Responding to DEA Visits
Prescribing Buprenorphine for OUD During a Public Health Emergency
All Posts By
joe
American Society for Pain Management Nursing Annual Conference: Updating and Encouraging Participation in Federal and State Policy
September 22, 2023
FDA Should Recall Software to Protect Patients
News
July 22, 2023
AMA Delegates: Stop Criminalizing Medicine
News
June 14, 2023
Rx Summit 2023: All Hands, All Branches: Expanding Advocacy to the Judicial Branch
March 16, 2023
Rx Summit 2023: Designing, Implementing, and Evaluating Large-Scale Stigma Reduction Campaigns
March 16, 2023
DEA Announces Removal of Buprenorphine Waiver Requirements
News
February 23, 2023
Federal Court Overturns CSA Conviction Following Ruan
News
February 23, 2023
Rx & Illicit Drug Summit: Digital Therapeutics: What They Are and How to Integrate Them in Addiction Treatment Workflows
February 11, 2023
HHS Proposes Permanent MOUD Regulatory Flexibilities
News
January 23, 2023
Second Patient Dies After DEA Suspends Physician’s Registration
News
December 15, 2022
Patient Dies After DEA Suspends Physician’s Registration
News
November 7, 2022
Federation of State Medical Boards Opioid Workgroup: “Recommendations To Improve Health Care Quality, Patient Autonomy and Privacy, and Provider Discretion”
September 28, 2022
More
